XML 67 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance $ 841 $ 767 $ 767
Additions 0 97  
Changes in estimated fair value 50 40  
Payments 0 (106)  
Other (12) 0  
Fair value, ending balance 879 798 841
Current liability 297    
Contingent consideration 879 $ 798 841
Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance 711    
Fair value, ending balance 759   711
Contingent consideration $ 759   $ 711
Contingent consideration, measurement input, discount rate (as percent) 0.115    
Measurement Input, Discount Rate | Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Contingent consideration, measurement input, discount rate (as percent) 0.08